SARS-CoV-2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice

Animal Model Exp Med. 2021 Mar 6;4(1):2-15. doi: 10.1002/ame2.12155. eCollection 2021 Mar.

Abstract

Background: Cardiovascular diseases (CVDs) and diabetes mellitus (DM) are top two chronic comorbidities that increase the severity and mortality of COVID-19. However, how SARS-CoV-2 alters the progression of chronic diseases remain unclear.

Methods: We used adenovirus to deliver h-ACE2 to lung to enable SARS-CoV-2 infection in mice. SARS-CoV-2's impacts on pathogenesis of chronic diseases were studied through histopathological, virologic and molecular biology analysis.

Results: Pre-existing CVDs resulted in viral invasion, ROS elevation and activation of apoptosis pathways contribute myocardial injury during SARS-CoV-2 infection. Viral infection increased fasting blood glucose and reduced insulin response in DM model. Bone mineral density decreased shortly after infection, which associated with impaired PI3K/AKT/mTOR signaling.

Conclusion: We established mouse models mimicked the complex pathological symptoms of COVID-19 patients with chronic diseases. Pre-existing diseases could impair the inflammatory responses to SARS-CoV-2 infection, which further aggravated the pre-existing diseases. This work provided valuable information to better understand the interplay between the primary diseases and SARS-CoV-2 infection.

Keywords: COVID‐19; Cardiovascular disease; SARS‐CoV‐2; diabetes mellitus; mouse model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • COVID-19 / complications*
  • COVID-19 / physiopathology*
  • Cardiovascular Diseases / complications*
  • Cardiovascular Diseases / physiopathology*
  • Comorbidity
  • Diabetes Complications / physiopathology*
  • Diabetes Mellitus
  • Disease Models, Animal
  • Male
  • Mice
  • SARS-CoV-2